Free cash flow turned sharply negative at -$23.5M in 2026Q2, with working capital swings of -$19.8M, despite cumulative operating cash flow of $36.4M exceeding cumulative net income of $18.0M over ten quarters.
MannKind Corporation (MNKD) cash flow statement — 24-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 |
|---|
| Cash from Operations | -66.52M | 18.25M | 42.51M | 34.09M | -80.7M | -61.71M | -28.13M | -88.48M | -37.73M | -64.78M | -78.09M | -57.23M | 4.09M | -128.73M | -119.86M | -123.84M | -148.65M | -184.08M | -271.29M | -245.15M | -189.79M | -101.23M | -59.91M | -52.77M | -48.67M |
| Operating CF Margin % | - | 5.23% | 14.89% | 17.14% | -80.88% | -81.8% | -43.18% | -140.36% | -135.44% | -551.54% | -44.68% | - | - | - | -342457.14% | -247674% | -159843.01% | - | -1356440% | -2451460% | -189794% | - | - | - | - |
| Operating CF Growth % | -676.02% | -57.06% | 24.69% | 142.25% | -30.77% | -119.39% | 68.21% | -134.51% | 41.75% | 17.05% | -36.44% | -1500.69% | 103.17% | -7.4% | 3.21% | 16.69% | 19.25% | 32.14% | -10.66% | -29.16% | -87.49% | -68.97% | -13.53% | -8.43% | - |
| Net Income | -74.82M | 5.86M | 27.59M | -11.94M | -87.4M | -80.93M | -57.24M | -51.9M | -86.97M | -117.33M | 125.66M | -368.44M | -198.38M | -191.49M | -169.37M | -160.8M | -170.56M | -220.1M | -303.04M | -293.19M | -230.55M | -114.34M | -75.99M | -65.88M | -206.26M |
| Depreciation & Amortization | 24.67M | 12.28M | 8.97M | 5.8M | 6.31M | 3.24M | 3.33M | 2.15M | 1.7M | 3.53M | 4.16M | 13.28M | 18.57M | 14.06M | 14.4M | 15.91M | 17.32M | 18.73M | 12.29M | 8.97M | 8.52M | 7.39M | 7.18M | 7.66M | 5.07M |
| Stock-Based Compensation | 23.64M | 24.2M | 21.36M | 17.65M | 0 | 12.2M | 6.51M | 6.2M | 6.86M | 4.85M | 5.13M | 8.72M | 48.62M | 45.19M | 13.29M | 11.2M | 13.58M | 20.22M | 24.79M | 17.64M | 14.67M | 0 | 4.5M | 0 | 0 |
| Deferred Taxes | -4.97M | -4.97M | 0 | 0 | 0 | 12.64M | 10.65M | -4.57M | 0 | 12.94M | -79.57M | 180.43M | 1.49M | 817K | 2.04M | 160.8M | 644K | 12.87M | 213K | -10.6M | -14.59M | 0 | -4.5M | 0 | 0 |
| Other Non-Cash Items | 95.27M | 67.23M | 21.07M | 7.96M | 24.45M | 8.86M | 18.4M | -28M | 5.71M | 3.67M | 5.79M | 67.81M | -10K | 2K | 6.49M | -160.81M | -6K | -7K | -237K | 18.59M | 16.95M | -1.86M | 7.32M | 7.34M | 151.65M |
| Working Capital Changes | -130.31M | -86.35M | -36.47M | 14.63M | -24.05M | -17.73M | -9.78M | -12.36M | 36.68M | 27.57M | -139.27M | 40.97M | 133.79M | 2.7M | 13.28M | 9.86M | -9.64M | -15.79M | -5.3M | 13.44M | 15.21M | 7.58M | 1.58M | -1.89M | 881K |
| Change in Receivables | -1.79M | -4.76M | 2.65M | 2.35M | -11.81M | -776K | -705K | 504K | -1.34M | -2.49M | -302K | 51.58M | -63.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -26.8M | 10.4M | -3.2M | 4.57M | -5.67M | -4.08M | -1.31M | -558K | -3.15M | -3.3M | -2.33M | -26.43M | -9.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -11.88M | -16.71M | -2.79M | -1.47M | 4.1M | 1.37M | 793K | -593K | -1.6M | 3.8M | -12.12M | 8.41M | 3.62M | -1.07M | 44K | 2.67M | -4.29M | -6.37M | -14.62M | 16.27M | 7.17M | 0 | -2.28M | 0 | 0 |
| Cash from Investing | -255.58M | -304.8M | -96.65M | -1.99M | 4.87M | -151.54M | 15.22M | -22.84M | -234K | 16.68M | -1.13M | -10.2M | -24.1M | -7.99M | -560K | -2.94M | -11.72M | -3.05M | -99.93M | 38.66M | -48.27M | -94.4M | -9.6M | 4.13M | -45.35M |
| Capital Expenditures | -12.16M | -4.57M | -9.69M | -42.44M | -7.59M | -11.47M | -4.78M | -2.56M | -354K | 0 | -1.14M | -10.29M | -24.1M | -7.99M | -637K | -6.86M | -9.54M | -18.85M | -82.45M | -78.26M | -20.77M | -17.17M | -6.89M | -5.18M | -34.15M |
| CapEx % of Revenue | 2.94% | 1.31% | 3.4% | 21.33% | 7.61% | 15.2% | 7.34% | 4.07% | 1.27% | - | 0.65% | - | - | - | 1820% | 13716% | 10260.22% | - | 412265% | 782620% | 20773% | - | - | - | - |
| Acquisitions | -347.74M | -347.74M | 0 | 0 | -15.34M | -56.06M | -3.98M | 0 | 120K | 24K | 17K | 82K | 0 | 0 | 0 | 0 | 0 | -70K | 0 | 0 | 0 | 90K | -75K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -16.41M | 128.71M | 382K | 32.8M | 56.06M | 20M | -300K | 120K | 16.68M | 17K | 82K | 0 | 0 | 77K | 93K | 0 | 70K | 70K | 0 | 32K | 583K | 75K | 75K | 0 |
| Cash from Financing | 235.99M | 315.1M | -137.27M | 136.61M | 21.41M | 270.27M | 49.85M | 69.86M | 61.29M | 73.56M | 43.04M | 5.67M | 70.06M | 145.67M | 179.58M | 63.39M | 196.42M | 189.51M | 30.59M | 255.21M | 501.58M | 172.68M | 101.48M | 82.85M | 60.2M |
| Debt Issued (Net) | 214.6M | 324.27M | -133.17M | -6.86M | -1.09M | 281.08M | 14.87M | 63.7M | -5M | 15.43M | -5M | -64.29M | 60M | 4.5M | 12.75M | 53M | 182.78M | 135M | 30M | 0 | 111.27M | 0 | 0 | 1.41M | -24K |
| Equity Issued (Net) | 52.38M | -3.26M | -6.09M | 6.89M | 22.56M | 1.89M | 23.66M | 3.2M | 70.52M | 58.25M | 50.89M | 68.68M | 12.34M | 53.52M | 167.74M | 10.94M | 17.02M | 61.51M | 902K | 255.74M | 390.66M | 172.68M | 84.73M | 49.59M | 58.91M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -3.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26.91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.03M | 0 |
| Other Financing | -30.99M | -5.91M | 1.99M | 136.58M | -62K | -12.7M | 11.31M | 2.97M | -4.22M | -120K | -2.85M | 1.27M | -2.28M | 87.64M | -906K | -547K | -3.39M | -7M | -317K | -524K | -340K | 0 | 16.75M | 31.85M | 1.31M |
| Net Change in Cash | -86.11M | 28.55M | -191.4M | 168.71M | -54.42M | 57.02M | 36.94M | -41.46M | 23.33M | 25.46M | -36.18M | -61.77M | 50.05M | 8.95M | 59.16M | -63.38M | 36.04M | 2.37M | -340.64M | 48.73M | 263.52M | -22.95M | 31.97M | 34.2M | -33.81M |
| Free Cash Flow | -78.69M | 13.69M | 32.82M | -8.35M | -88.29M | -73.17M | -32.91M | -91.05M | -38.09M | -64.78M | -79.23M | -67.52M | -20.01M | -136.72M | -120.5M | -130.69M | -158.2M | -202.94M | -353.74M | -323.41M | -210.57M | -118.4M | -66.81M | -57.95M | -82.81M |
| FCF Margin % | -19.04% | 3.92% | 11.49% | -4.2% | -88.49% | -97% | -50.52% | -144.43% | -136.71% | -551.54% | -45.34% | - | - | - | -344277.14% | -261390% | -170103.23% | - | -1768705% | -3234080% | -210567% | - | - | - | - |
| FCF Growth % | -281.99% | -58.29% | 493.17% | 90.55% | -20.65% | -122.34% | 63.85% | -139.07% | 41.21% | 18.24% | -17.35% | -237.4% | 85.36% | -13.46% | 7.8% | 17.38% | 22.05% | 42.63% | -9.38% | -53.59% | -77.85% | -77.23% | -15.27% | 30.02% | - |
| FCF per Share | -0.25 | 0.04 | 0.12 | -0.03 | -0.34 | -0.29 | -0.15 | -0.47 | -0.26 | -0.62 | -0.86 | -0.83 | -0.26 | -2.28 | -3.33 | -5.36 | -6.96 | -9.52 | -17.42 | -20.20 | -20.66 | -14.85 | -13.24 | -15.67 | -30.74 |
| FCF Conversion (FCF/Net Income) | 1.05x | 3.11x | 1.54x | -2.86x | 0.92x | 0.76x | 0.49x | 1.70x | 0.43x | 0.55x | -0.62x | 0.16x | -0.02x | 0.67x | 0.71x | 0.77x | 0.87x | 0.84x | 0.90x | 0.84x | 0.82x | 0.89x | 0.79x | 0.80x | 0.24x |
| Interest Paid | 14.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.76M | 7.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.31M | 4.35M | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 777K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 240K | 51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 3K | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying MNKD stock.
MannKind Corporation (MNKD) generated $18.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
MannKind Corporation (MNKD) generated $13.7M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
MannKind Corporation (MNKD) spent $4.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, MannKind Corporation (MNKD) spent $3.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Liquidia litigation overhang
Metrics are mathematically derived from official filings.
Earnings Quality Masked by Volatile Accruals
Operating cash flow swung from $23.5M in 2025Q3 to -$18.4M in 2026Q2, while net income moved inversely, per financial statements, indicating accrual-driven earnings quality.
The OCF/NI ratio ranged from -1.90 to 13.40 across the ten quarters, with 2026Q2 showing OCF/NI of 0.97 despite a net loss, suggesting that non-cash items like SBC and D&A are significant. The large negative working capital changes in 2025Q4 (-$72.1M) and 2026Q2 (-$19.8M) appear to be the primary drivers of cash flow volatility, not operational deterioration. Investors should monitor whether these swings reflect timing of collaboration payments or inventory build-up, as they obscure the underlying cash generation.
Free Cash Flow Turns Negative on Working Capital
FCF margin collapsed from 27.2% in 2025Q3 to -21.4% in 2026Q2, per reported figures, as working capital outflows overwhelmed revenue growth, reversing the positive trajectory seen in late 2025.
The positive FCF quarters in 2025Q3 and 2024Q4 were driven by favorable working capital swings, while 2026Q2's -$23.5M FCF reflects a $19.8M working capital outflow. Despite revenue accelerating 42.9% YoY, the cash conversion has deteriorated, suggesting that growth is consuming cash rather than generating it. This may indicate that MNKD is funding receivables or inventory to support the Tyvaso DPI ramp, but the sustainability of this pattern warrants close monitoring.
Capital Intensity Remains Modest but Rising
CapEx/Revenue averaged 2.5% over the last ten quarters, but 2026Q2 saw a jump to 4.6%, as per SEC filings, suggesting increased investment in manufacturing capacity.
The absolute CapEx of $5.1M in 2026Q2 is the highest in the dataset, yet it remains low relative to revenue, indicating that the Danbury facility is largely built out. The increase may reflect maintenance or expansion for Tyvaso DPI production, but the modest capital intensity suggests that future growth can be supported without significant incremental investment. However, if the company needs to scale capacity for new pipeline candidates, CapEx could rise, pressuring FCF.
Working Capital Swings Distort Cash Flow
Working capital changes ranged from -$72.1M in 2025Q4 to -$0.8M in 2025Q3, per financial statements, indicating significant volatility likely tied to collaboration milestones and inventory management.
The large negative working capital changes in 2025Q4 and 2026Q2 suggest that cash is being tied up in receivables or inventory, possibly due to the timing of Tyvaso DPI shipments or milestone payments. The positive OCF in 2025Q3 and 2024Q4 coincided with smaller working capital outflows, implying that the underlying business generates cash when working capital normalizes. Investors should assess whether these swings are seasonal or indicative of structural inefficiencies in collections or payables.
No Capital Returns, Focus on Debt Reduction
No dividends or buybacks were reported in any quarter, while a $347.7M acquisition outflow in 2025Q4, per reported figures, suggests capital is being deployed toward strategic investments.
The absence of shareholder returns indicates that management is prioritizing balance sheet strengthening and growth investments. The large acquisition outflow in 2025Q4 may be related to a partnership or asset purchase, but its nature is not disclosed. Given the historical reliance on convertible debt, investors should monitor whether future cash flows are used to de-lever or fund pipeline development, as this will determine the equity story.
Cumulative Cash Generation Lags Net Income
Over the ten quarters, cumulative net income was $18.0M while cumulative operating cash flow was $36.4M, per reported figures, indicating that cash generation has exceeded earnings.
The positive cumulative OCF relative to net income suggests that non-cash charges like D&A and SBC are inflating the gap, but the volatility in working capital has created uneven cash flows. The 2025Q4 acquisition outflow of $347.7M is a one-time item that distorts the cumulative picture, but excluding it, OCF would be even higher. This divergence implies that the company's earnings quality is reasonable, but the timing of cash flows is unpredictable, which may complicate valuation.
What Could Undermine the Royalty Thesis
The reliance on Tyvaso DPI royalties exposes MNKD to competitive and regulatory risks, as Liquidia's litigation could erode market share, while the 2026Q2 operating loss suggests cost overruns.
The cash flow statement obscures the potential impact of Liquidia's legal challenges on the core royalty stream, which could reduce future cash inflows if market share is lost. Additionally, the 2026Q2 operating loss of $350K, despite revenue growth, indicates that SG&A escalation may be outpacing cash generation, potentially straining liquidity. Investors should monitor whether the company can maintain positive operating cash flow while managing legal and competitive pressures, as the current cash flow volatility may not fully reflect these risks.